Stockholm - Delayed Quote SEK

BrainCool AB (publ) (BRAIN.ST)

Compare
1.3000
-0.0020
(-0.15%)
At close: January 17 at 5:29:34 PM GMT+1
Loading Chart for BRAIN.ST
DELL
  • Previous Close 1.3020
  • Open 1.3100
  • Bid 1.2960 x --
  • Ask 1.3000 x --
  • Day's Range 1.2740 - 1.3220
  • 52 Week Range 1.1600 - 4.7700
  • Volume 77,387
  • Avg. Volume 278,623
  • Market Cap (intraday) 329.408M
  • Beta (5Y Monthly) 1.65
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitors and controls patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powered cooling product to spray liquid coolant for patient's nostrils with a catheter, as well as provides Cooral system provides medical professionals an easy way to reduce the risk of oral mucositis; and IQool system, a single-use cooling system used as silicone cooling pads for patient's care. In addition, the company provides products for medical cooling treatments for diseases, including stroke, cardiac arrest, neurological fever, chemotherapy, and oral mucositis. BrainCool AB (publ) was incorporated in 2010 and is based in Lund, Sweden.

braincoolinc.com

20

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BRAIN.ST

View More

Performance Overview: BRAIN.ST

Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

BRAIN.ST
4.83%
OMX Stockholm 30 Index
5.41%

1-Year Return

BRAIN.ST
72.86%
OMX Stockholm 30 Index
12.64%

3-Year Return

BRAIN.ST
78.07%
OMX Stockholm 30 Index
10.99%

5-Year Return

BRAIN.ST
73.43%
OMX Stockholm 30 Index
44.42%

Compare To: BRAIN.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BRAIN.ST

View More

Valuation Measures

Annual
As of 1/17/2025
  • Market Cap

    329.41M

  • Enterprise Value

    313.43M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.79

  • Price/Book (mrq)

    2.14

  • Enterprise Value/Revenue

    8.36

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -141.57%

  • Return on Assets (ttm)

    -19.50%

  • Return on Equity (ttm)

    -39.83%

  • Revenue (ttm)

    40.67M

  • Net Income Avi to Common (ttm)

    -57.58M

  • Diluted EPS (ttm)

    -0.2400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    41.27M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -50.66M

Research Analysis: BRAIN.ST

View More

Company Insights: BRAIN.ST

Research Reports: BRAIN.ST

View More

People Also Watch